81 related articles for article (PubMed ID: 12121219)
1. Tolerization as a tool for generating novel monoclonal antibodies.
Holbrook FL; Nicholson IC; Zola H
Immunol Cell Biol; 2002 Aug; 80(4):319-22. PubMed ID: 12121219
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immunization techniques to obtain highly specific monoclonal antibodies.
de Almeida R; Nakamura CN; de Lima Fontes M; Deffune E; Felisbino SL; Kaneno R; Fávaro WJ; Billis A; Cerri MO; Fusco-Almeida AM; Mendes Giannini MJ; Moroz A
MAbs; 2018 Jan; 10(1):46-54. PubMed ID: 28581886
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a murine monoclonal antibody to cervical glandular epithelium using mice rendered tolerant to cervical squamous epithelium.
Imam A; Stathopoulos E; Taylor CR
Hybridoma; 1990 Apr; 9(2):157-66. PubMed ID: 2189826
[TBL] [Abstract][Full Text] [Related]
4. Generation of a murine monoclonal antibody to normal mammary epithelium using mice rendered immune-tolerant to malignant mammary epithelium.
Imam SA; Esteban EF; Young LL; Taylor CR
J Histochem Cytochem; 1994 May; 42(5):585-91. PubMed ID: 7512585
[TBL] [Abstract][Full Text] [Related]
5. Subtractive immunization techniques for the production of monoclonal antibodies to rare antigens.
Williams CV; Stechmann CL; McLoon SC
Biotechniques; 1992 Jun; 12(6):842-7. PubMed ID: 1642892
[TBL] [Abstract][Full Text] [Related]
6. Multiple Tolerization Subtractive Immunization (MTSI) Protocol: Effects on Mice and Monoclonal Antibody Specificity.
de Lima Fontes M; Neves FML; Santos KS; Fusco-Almeida AM; Giannini MJSM; Felisbino SL; Deffune E; Moroz A
Front Immunol; 2021; 12():760817. PubMed ID: 34950138
[TBL] [Abstract][Full Text] [Related]
7. Targeting the proteome/epitome, implementation of subtractive immunization.
Zijlstra A; Testa JE; Quigley JP
Biochem Biophys Res Commun; 2003 Apr; 303(3):733-44. PubMed ID: 12670472
[TBL] [Abstract][Full Text] [Related]
8. Increased proportion of antigen-specific antibody-producing hybridomas following an in vitro immunization with in vivo immunized mouse spleen cells.
Enriquez FJ; Bradley-Dunlop D; Joens L
Hybridoma; 1991 Dec; 10(6):745-51. PubMed ID: 1816073
[TBL] [Abstract][Full Text] [Related]
9. Hybridoma technologies for antibody production.
Tomita M; Tsumoto K
Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
[TBL] [Abstract][Full Text] [Related]
10. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and characterization of a monoclonal antibody against human c-Kit].
Liu HC; Mao CM; Su XY; Ruan Z; Ding QL; Wang XF; Wang HL; Xi XD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):619-22. PubMed ID: 19737481
[TBL] [Abstract][Full Text] [Related]
12. Preparation of monoclonal antibodies to murine platelet glycoprotein IIb/IIIa (alphaIIbbeta3) and other proteins from hamster-mouse interspecies hybridomas.
Lengweiler S; Smyth SS; Jirouskova M; Scudder LE; Park H; Moran T; Coller BS
Biochem Biophys Res Commun; 1999 Aug; 262(1):167-73. PubMed ID: 10448087
[TBL] [Abstract][Full Text] [Related]
13. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to Treponema pallidum.
van de Donk HJ; van Embden JD; de Jong A; van Olderen MF; Osterhaus AD
Dev Biol Stand; 1984; 57():107-11. PubMed ID: 6396126
[TBL] [Abstract][Full Text] [Related]
17. Hybridoma Technology.
Hnasko RM; Stanker LH
Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
[TBL] [Abstract][Full Text] [Related]
18. Production and Screening of Monoclonal Peptide Antibodies.
Trier NH; Mortensen A; Schiolborg A; Friis T
Methods Mol Biol; 2015; 1348():109-26. PubMed ID: 26424268
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
Ding H; Wang JY; Song HY
Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
[TBL] [Abstract][Full Text] [Related]
20. Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope "tags".
Percival-Alwyn JL; England E; Kemp B; Rapley L; Davis NH; McCarthy GR; Majithiya JB; Corkill DJ; Welsted S; Minton K; Cohen ES; Robinson MJ; Dobson C; Wilkinson TC; Vaughan TJ; Groves MA; Tigue NJ
MAbs; 2015; 7(1):129-37. PubMed ID: 25523454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
